Name: UMIN ID:
Unique ID issued by UMIN | UMIN000009872 |
---|---|
Receipt number | R000011568 |
Scientific Title | Phase II study of continuation maintenance by use of TS1 after induction chemotherapy of cisplatin and TS1 in patients with Stage IIIB / IV non-small cell lung cancer-Research of efficacy predictive biomarker |
Date of disclosure of the study information | 2013/01/31 |
Last modified on | 2019/03/30 15:23:49 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/01/25 17:41:11 | ||
2 | Update | 2013/08/25 10:53:53 | Email |
|
3 | Update | 2014/01/25 09:24:33 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
4 | Update | 2016/09/02 16:14:41 | Name of primary person or sponsor Organization |
|
5 | Update | 2018/09/29 16:34:18 | Name of primary person or sponsor Co-sponsor Co-sponsor |
|
6 | Update | 2018/09/29 16:38:40 | Last follow-up date |
|
7 | Update | 2019/02/01 20:04:39 | Last follow-up date |
|
8 | Update | 2019/02/01 20:22:15 | Other related information Other related information |
|
9 | Update | 2019/03/30 15:22:01 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization1 Organization Organization Address Address Tel |
|
10 | Update | 2019/03/30 15:22:39 | Recruitment status Date of IRB |
|
11 | Update | 2019/03/30 15:23:49 | Number of participants that the trial has enrolled |